• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Clinical characteristics and survival of colorectal cancer patients in Korea stratified by age.韩国按年龄分层的结直肠癌患者的临床特征与生存情况
Korean J Intern Med. 2021 Jul;36(4):985-991. doi: 10.3904/kjim.2019.066. Epub 2021 Apr 6.
2
Treatment patterns and survival differ between early-onset and late-onset colorectal cancer patients: the patient outcomes to advance learning network.治疗模式和生存结果在早发性和晚发性结直肠癌患者之间存在差异:患者结局提升学习网络。
Cancer Causes Control. 2019 Jul;30(7):747-755. doi: 10.1007/s10552-019-01181-3. Epub 2019 May 17.
3
The Risk of Colorectal Cancer After Cholecystectomy or Appendectomy: A Population-based Cohort Study in Korea.胆囊切除术或阑尾切除术后患结直肠癌的风险:韩国一项基于人群的队列研究。
J Prev Med Public Health. 2018 Nov;51(6):281-288. doi: 10.3961/jpmph.18.105. Epub 2018 Oct 29.
4
Comparing Clinical Characteristics and Outcomes of Young-onset and Late-onset Colorectal Cancer: An International Collaborative Study.比较早发性和迟发性结直肠癌的临床特征和结局:一项国际合作研究。
Clin Colorectal Cancer. 2017 Dec;16(4):334-342. doi: 10.1016/j.clcc.2017.03.008. Epub 2017 Mar 21.
5
Role of cyclooxygenase-2 inhibitors in the survival outcome of colorectal cancer patients: A population-based cohort study.环氧化酶-2抑制剂在结直肠癌患者生存结局中的作用:一项基于人群的队列研究。
Kaohsiung J Med Sci. 2017 Jun;33(6):308-314. doi: 10.1016/j.kjms.2017.03.004. Epub 2017 Apr 2.
6
Efficacy of surgery and adjuvant therapy in older patients with colorectal cancer: a STROBE-compliant article.手术及辅助治疗对老年结直肠癌患者的疗效:一篇符合STROBE标准的文章。
Medicine (Baltimore). 2014 Dec;93(28):e266. doi: 10.1097/MD.0000000000000266.
7
Increased risk of colorectal neoplasia among family members of patients with colorectal cancer: a population-based study in Utah.结直肠癌患者家庭成员结直肠肿瘤发病风险增加:犹他州基于人群的研究。
Gastroenterology. 2014 Oct;147(4):814-821.e5; quiz e15-6. doi: 10.1053/j.gastro.2014.07.006. Epub 2014 Jul 17.
8
The increased risk of colorectal cancer in the women who underwent hysterectomy from the South Korean National Health Insurance Database.韩国国家健康保险数据库中接受子宫切除术的女性中结直肠癌风险增加。
BMC Womens Health. 2023 Sep 29;23(1):519. doi: 10.1186/s12905-023-02642-3.
9
Different clinical characteristics in sporadic young-age onset colorectal cancer.散发性青年发病型结直肠癌的不同临床特征。
Medicine (Baltimore). 2016 Sep;95(37):e4840. doi: 10.1097/MD.0000000000004840.
10
Data on the characteristics and the survival of korean patients with colorectal cancer from the Korea central cancer registry.来自韩国中央癌症登记处的韩国结直肠癌患者的特征和生存数据。
Ann Coloproctol. 2013 Aug;29(4):144-9. doi: 10.3393/ac.2013.29.4.144. Epub 2013 Aug 29.

引用本文的文献

1
Novel genetic loci and functional properties of immune-related genes for colorectal cancer survival in Korea.韩国结直肠癌生存相关免疫相关基因的新型遗传位点及功能特性
BMC Cancer. 2025 Mar 13;25(1):456. doi: 10.1186/s12885-025-13819-4.
2
Comprehensive profiling of DNA methylation in Korean patients with colorectal cancer.韩国结直肠癌患者 DNA 甲基化的综合分析。
BMB Rep. 2024 Feb;57(2):110-115. doi: 10.5483/BMBRep.2023-0093.
3
Disparities in All-Cause Mortality in Older Patients with Colorectal Cancer According to Disability Status: A Nationwide Analysis.基于残疾状况的老年结直肠癌患者全因死亡率的差异:一项全国性分析。
Curr Oncol. 2022 Oct 5;29(10):7430-7438. doi: 10.3390/curroncol29100584.
4
Association between Timing and Duration of Adjuvant Chemotherapy and Colorectal Cancer Survival in Korea, 2011-2014: A Nationwide Study based on the Health Insurance Review and Assessment Service Database.2011 - 2014年韩国辅助化疗的时间和持续时间与结直肠癌生存率的关联:一项基于健康保险审查与评估服务数据库的全国性研究
J Cancer. 2022 May 1;13(8):2440-2446. doi: 10.7150/jca.71141. eCollection 2022.

本文引用的文献

1
Treatment of Elderly Patients with Colorectal Cancer.老年结直肠癌患者的治疗。
Biomed Res Int. 2018 Mar 11;2018:2176056. doi: 10.1155/2018/2176056. eCollection 2018.
2
Colorectal cancer statistics, 2017.结直肠癌统计数据,2017 年。
CA Cancer J Clin. 2017 May 6;67(3):177-193. doi: 10.3322/caac.21395. Epub 2017 Mar 1.
3
Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2012.韩国癌症统计数据:2012年的发病率、死亡率、生存率及患病率
Cancer Res Treat. 2015 Apr;47(2):127-41. doi: 10.4143/crt.2015.060. Epub 2015 Mar 3.
4
Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010.美国 1975-2010 年结肠癌和直肠癌年龄相关发病率的差距日益增大。
JAMA Surg. 2015 Jan;150(1):17-22. doi: 10.1001/jamasurg.2014.1756.
5
Colorectal cancer statistics, 2014.结直肠癌统计数据,2014 年。
CA Cancer J Clin. 2014 Mar-Apr;64(2):104-17. doi: 10.3322/caac.21220. Epub 2014 Mar 17.
6
Colorectal cancer in elderly patients: from best supportive care to cure.老年患者结直肠癌:从最佳支持治疗到治愈。
Anticancer Agents Med Chem. 2013 Nov;13(9):1332-43. doi: 10.2174/18715206113136660350.
7
Comparison of recurrence patterns between ≤5 years and >5 years after curative operations in colorectal cancer patients.结直肠癌患者根治性手术后 5 年以内和 5 年以上复发模式的比较。
J Surg Oncol. 2013 Jul;108(1):9-13. doi: 10.1002/jso.23349. Epub 2013 Jun 10.
8
Population-based data from the Swedish Colon Cancer Registry.基于瑞典结肠癌登记处的人群数据。
Br J Surg. 2013 Jul;100(8):1100-7. doi: 10.1002/bjs.9166. Epub 2013 May 21.
9
Increasing trend of colorectal cancer incidence in Korea, 1999-2009.韩国 1999-2009 年结直肠癌发病率的上升趋势。
Cancer Res Treat. 2012 Dec;44(4):219-26. doi: 10.4143/crt.2012.44.4.219. Epub 2012 Dec 31.
10
Effect of adjuvant chemotherapy on survival of patients with stage III colon cancer diagnosed after age 75 years.辅助化疗对 75 岁以后诊断为 III 期结肠癌患者生存的影响。
J Clin Oncol. 2012 Jul 20;30(21):2624-34. doi: 10.1200/JCO.2011.41.1140. Epub 2012 Jun 4.

韩国按年龄分层的结直肠癌患者的临床特征与生存情况

Clinical characteristics and survival of colorectal cancer patients in Korea stratified by age.

作者信息

Baek Sun Kyung, Lee Ji Sung, Hwang In Gyu, Kim Jong Gwang, Kim Tae Won, Sohn Seung Kook, Kang Mi Yeon, Lee Sang-Cheol

机构信息

Department of Internal Medicine, Kyung Hee University Hospital, Seoul, Korea.

Clinical Research Center, Asan Medical Center, Seoul, Korea.

出版信息

Korean J Intern Med. 2021 Jul;36(4):985-991. doi: 10.3904/kjim.2019.066. Epub 2021 Apr 6.

DOI:10.3904/kjim.2019.066
PMID:33820397
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8273826/
Abstract

BACKGROUND/AIMS: This nationwide study was undertaken to determine differences in clinicopathologic characteristics and survival of patients with colorectal cancer (CRC) according to age using big data from the Korean National Health Insurance Service (NHIS).

METHODS

The NHIS data including quality assessment of CRC by the Health Insurance Review & Assessment Service in Korea between 2011 and 2014 were analyzed. Based on age, patients were divided into three groups: not-old patients (< 65), young-old patients (65 to 74 years old) and old-old patients (≥ 75 years old).

RESULTS

We included 71,513 CRC patients. The median follow-up duration was 3.2 years (range, 0.003 to 5.5). Male patients constituted 60%. The median age of patients was 65 years (range, 18 to 102). Colon was the cancer site in 59.8% of not-old patients, 62.9% of young-old patients, and 66.1% of old-old patients. Compared to not-old patients, young-old and old-old patients were more likely to be diagnosed with colon adenocarcinoma and well/moderate differentiation or adequate differentiation (all p < 0.001). Old patients underwent more emergency operation (p < 0.001) and received less adjuvant therapy in stage I-III (p < 0.001). The probability of 3-year survival of young-old or old-old patients was worse than that for not-old patients (hazard ratio [HR], 1.55; 95% confidence interval [CI], 1.46 to 1.64) (HR, 3.19; 95% CI, 3.03 to 3.37).

CONCLUSION

Old patients with CRC show different histology from younger patients. They are more frequently to have colon as primary lesion. They undergo less adjuvant therapy. Further studies and evidence-based guidelines for older patients with CRC are warranted to improve their outcome.

摘要

背景/目的:本全国性研究旨在利用韩国国民健康保险服务(NHIS)的大数据,确定不同年龄的结直肠癌(CRC)患者在临床病理特征和生存方面的差异。

方法

分析了2011年至2014年韩国健康保险审查与评估服务机构对CRC进行质量评估的NHIS数据。根据年龄,患者分为三组:非老年患者(<65岁)、年轻老年患者(65至74岁)和老年老年患者(≥75岁)。

结果

我们纳入了71513例CRC患者。中位随访时间为3.2年(范围,0.003至5.5年)。男性患者占60%。患者的中位年龄为65岁(范围,18至102岁)。非老年患者中59.8%的癌症部位在结肠,年轻老年患者中为62.9%,老年老年患者中为66.1%。与非老年患者相比,年轻老年和老年老年患者更有可能被诊断为结肠腺癌以及高/中分化或充分分化(所有p<0.001)。老年患者接受急诊手术的比例更高(p<0.001),在I-III期接受辅助治疗的比例更低(p<0.001)。年轻老年或老年老年患者的3年生存率低于非老年患者(风险比[HR],1.55;95%置信区间[CI],1.46至1.64)(HR,3.19;95%CI,3.03至3.37)。

结论

老年CRC患者的组织学表现与年轻患者不同。他们更常以结肠作为原发病变。他们接受的辅助治疗较少。有必要针对老年CRC患者开展进一步研究并制定基于证据的指南,以改善其治疗效果。